Angela Huttner

Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum

Angela Huttner, Stephan Harbarth, Jean Carlet et al. · Antimicrobial Resistance and Infection Control · 2013 · 451 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Angela Huttner, Julie-Anne Dayer, Sabine Yerly et al. · The Lancet Infectious Diseases · 2015 · 278 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia

Elodie von Dach, Werner C. Albrich, Anne-Sophie Brunel et al. · JAMA · 2020 · 251 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study

Angela Huttner, Elodie von Dach, Adriana Renzoni et al. · International Journal of Antimicrobial Agents · 2015 · 220 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women

Angela Huttner, Anna Kowalczyk, ‪Adi Turjeman‬‏ et al. · JAMA · 2018 · 213 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13